Pfizer needs a big deal, analysts say; Allergan ‘makes sense’

(Reuters) – Allergan Plc’s shares soared as much as 16 percent in premarket trading on Thursday, a day after media reports that Pfizer Inc had held early talks with the Botox-maker about a deal that would create the world’s biggest drugmaker. A combination of Dublin-based Allergan with New York-based Pfizer would create a $ 330-billion pharma giant and extend an unprecedented wave of consolidation in the industry as companies seek access to new drugs and increased leverage on pricing. Maxim Jacobs, an analyst at Edison Investment Research, said a deal would make sense for Pfizer.
Medications/Drugs News Headlines – Yahoo! News

Pharmaceutical Stocks


© 2018 Drugs News All rights reserved.       Privacy Policy       Contact Us